The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma

 
View all videos

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma

 
View all videos

Find out more about novel developments in R/R #Hodgkin lymphoma, including the promise of checkpoint inhibitors, bispecifics and CAR-T cells, in our exclusive interview with Graham Collins (@graham74GC):

👉http://ow.ly/9aXO50LM8BP👈

#LymSM #ImmunoOnc #HemOnc #ISHL12

#ESHCML2022 | Camille Kockerols (@asznl) comments on the efficacy and tolerability of asciminib in patients with CML who are intolerant or resistant to TKIs:

🎥: http://ow.ly/1Nxh50LM89Q

@ESHaematology #LeuSM #CMLsm #HemOnc

With just two weeks to go, we're so excited for #ASH22! 🤩

Find out more about what to look forward to at this year's meeting from leading expert @IreneGhobrial!

@ASH_hematology #MMsm #LymSM #LeuSM #HemOnc #ImmunoOnc

Saad Kenderian (@kenderian_ss) of @MayoClinic discusses the current challenges and opportunities regarding CAR-T cell therapy and the tumor microenvironment at #SOHO22:

🎥: http://ow.ly/Kf0Q50LM7L3

#HemOnc #ImmunoOnc #CARTcell

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter